FDA Authorizes Generic Lurasidone Hydrochloride Tablets

Article

The FDA has approved marketing of Lupin Pharmaceuticals’ Lurasidone Hydrochloride Tablets, a generic version of Sunovion Pharmaceuticals, Inc's lurasidone HCl (Latuda) tablets.

The FDA has approved marketing of Lupin Pharmaceuticals’ Lurasidone Hydrochloride Tablets, a generic version of Sunovion Pharmaceuticals, Inc's lurasidone HCl (Latuda) tablets, according to the company. Both products are approved for 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg.

According to Lupin's announcement, its Lurasidone Hydrochloride Tablets are indicated for treatment of adult patients with schizophrenia, monotherapy treatment of adult patients with major depressive episode associated with bipolar I disorder, and adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder.

Reference

Lupin receives FDA approval for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg [news release]. Mumbai, India and Baltimore, MD; January 7, 2019: Lupin Pharmaceuticals website. http://www.lupinpharmaceuticals.com/lupin-receives-fda-approval-for-lurasidone-hydrochloride-tablets-20-mg-40-mg-60-mg-80-mg-120-mg.htm?rel=0" ?rel=0" . Accessed January 7, 2019.

Related Videos
Therapy session -- Image credit: pressmaster | stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
Medical team -- Image credit: Flamingo Images | stock.adobe.com
Young depressed woman talking to lady psychologist during session, mental health - Image credit: motortion | stock.adobe.com
man taking opioid pills sitting at a dark table - Image credit: rohane | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.